Trevena
TRVN
$0.39
Share price
-4.40%
Change (1 day)
-39.85%
Change (1 year)
Categories
Trevena (TRVN) - Net assets
Net assets on the balance sheet as of September 2023 : $3.54 M
According to Trevena's latest financial reports the company has $3.54 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Trevena - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $15.59 M | -75.86% |
| 2021-12-31 | $64.62 M | -37.9% |
| 2020-12-31 | $0.10 B | 245.99% |
| 2019-12-31 | $30.07 M | -27.57% |
| 2018-12-31 | $41.52 M | 19.9% |
| 2017-12-31 | $34.63 M | -55.93% |
| 2016-12-31 | $78.58 M | -45.1% |
| 2015-12-31 | $0.14 B | 44.28% |
| 2014-12-31 | $99.2 M | 154.42% |
| 2013-12-31 | $38.99 M | -99616.42% |
| 2012-12-31 | $-0.04 M | -100.25% |
| 2011-12-31 | $15.41 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $6.23 B | 175,498.76% | 🇺🇸 USA |
 Merck MRK | $37.63 B | 1,060,339.56% | 🇺🇸 USA |
 Cytokinetics
CYTK | -$0.39 B | -10,985.40% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $14.1 M | 297.44% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $57.08 M | 1,508.48% | 🇺🇸 USA |